Renke Tan

Renke Tan

Auto-generated profile, based on publicly available information

Renke Tan

Stanford Cardiovascular Institute (H.Z., R.H., L.R., W.Z., Y.D., W.L., M.X., X.L., R.T., X.Y., X.C., X.W., J.C.W.), Stanford University School of Medicine, Stanford, CA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2018 in Blood
Verified
Journal Article
Open access
PDF file
WJWei Jiang
Wei Jiang
XZXiaoyan Zhou
Xiaoyan Zhou
ZLZengxia Li
Zengxia Li
KLKaiyu Liu
Kaiyu Liu
WWWeige Wang
Weige Wang
YDYongjun Dang
Yongjun Dang
Key Points: P4HA2, associated with progression and poor overall survival in DLBCL patients, could serve as a novel biomarker and therapeutic target. P4HA2 counteracts the negative effect of Carabin on lymphoma by hydroxylation of Carabin at Pro306.

25 July 2019 in Protein & Cell
Verified
Journal Article
Open access
PDF file
SJShuai Jiang
Shuai Jiang
JWJiaqi Wang
Jiaqi Wang
CYChen Yang
Chen Yang
RTRenke Tan
Renke Tan
JHJun Hou
Jun Hou
YDYongjun Dang
Yongjun Dang

25 September 2020 in Genes & Diseases
Verified
Journal Article
Open access
RTRenke Tan
Renke Tan
WDWenhao Du
Wenhao Du
YLYiyang Liu
Yiyang Liu
XCXiaoji Cong
Xiaoji Cong
MBMeirong Bai
Meirong Bai
YDYongjun Dang
Yongjun Dang
The CRISPR/Cas9 system, originally derived from the prokaryotic adaptive immune system, has been developed as efficient genome editing tools. It enables precise gene manipulation on chromosomal DNA through the specific binding of programmable sgRNA to target DNA, and the Cas9 protein, which has endonuclease activity, will cut a double strand break at specific locus. However, Cas9 is a foreign protein in mammalian cells, and the potential risks associated with its introduction into mammalian cells are not fully understood. In this study, we performed pull-down and mass spectrometry (MS) analysis of Streptococcus pyogenes Cas9 (SpyCas9) interacting proteins in HEK293T cells and showed that the majority of Cas9-associated proteins identified by MS were localized in the nucleolus. Interestingly, we further discovered that the Cas9 protein contains a sequence encoding a nucleolus detention signal (NoDS). Compared with wild-type (WT) Cas9, NoDS-mutated variants of Cas9 (mCas9) are less stable, although their gene editing activity is minimally affected. Overexpression of WT Cas9, but not mCas9, causes general effects on transcription and protein translation in the host cell. Overall, identification of NoDS in Cas9 will improve the understanding of Cas9's biological function in vivo, and the removal of NoDS in Cas9 may enhance its safety for future clinical use.

1 October 2019 in Cell Chemical Biology
Verified
Journal Article
Closed access
CJChenxiao Jiang
Chenxiao Jiang
YTYegen Tang
Yegen Tang
LDLulu Ding
Lulu Ding
RTRenke Tan
Renke Tan
XLXiaojing Li
Xiaojing Li
YDYongjun Dang
Yongjun Dang

9 October 2026 in Circulation Research
Verified
Journal Article
Open access
HZHao Zhang
Hao Zhang
RHRihua Huang
Rihua Huang
PTPhung Thai
Phung Thai
LRLU Ren
LU Ren
RSRabindra V. Shivnaraine
Rabindra V. Shivnaraine
JWJoseph C. Wu
Joseph C. Wu

28 March 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
KZKristina Zdantsevich
Kristina Zdantsevich
RTRenke Tan
Renke Tan
DLDong Li
Dong Li
PWParker Walther
Parker Walther
ULUri Ladabaum
Uri Ladabaum
JWJoseph C. Wu
Joseph C. Wu
PTEN Hamartoma Tumor Syndrome (PHTS) is an inherited condition caused by germline mutations in PTEN, characterized by abnormal development and an elevated cancer risk driven by altered PI3K–AKT signaling. To model this disease in vitro, we derived human induced pluripotent stem cell (iPSC) lines SCVIi142-A and SCVIi143-A from two male donors clinically diagnosed with PHTS carrying heterozygous PTEN mutations. Both lines displayed undifferentiated iPSC morphology, robust expression of undifferentiated iPSC state markers, trilineage differentiation capacity, normal karyotypes, and validated PTEN variants. These iPSC lines provide a patient-specific platform for studying PTEN-associated developmental and signaling abnormalities.